Ongoing Disclosure Notice – Various

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Heartland Group Holdings Limited
Date this disclosure made:
5 September 2022
Date of last disclosure:
8 November 2018
Director or senior manager giving disclosure
Full name(s):
Geoffrey Thomas Ricketts
Name of listed issuer:
Heartland Group Holdings Limited
Name of related body corporate (if applicable):
Not applicable
Position held in listed issuer:
Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary Shares in Heartland Group
Holdings Limited (NZX/ASX: HGH)
Nature of the affected relevant interest(s):
Beneficial Owner
For that relevant interest-
Number held in class before acquisition or disposal:
13,267,285
Number held in class after acquisition or disposal:
14,933,951
Current registered holder(s):
Oceania & Eastern Limited
Registered holder(s) once transfers are registered:
Not applicable
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Not applicable
Class of underlying financial products:
Not applicable
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative(if any):
Not applicable
The price specified in the terms of the derivative (if any):
Not applicable
Any other details needed to understand how the amount of the consideration
payable under the derivative or the value of the derivative is affected by the value of
the underlying financial products:
Not applicable
For that derivative,-
Parties to the derivative:
Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1

Details of transactions requiring disclosure-
Date of transaction:29 August 2022
Nature of transaction:
Acquisition of shares under
Heartland's fully underwritten
NZ$130 million placement
announced on 23 August 2022.
Name of any other party or parties to the transaction (if known):Not applicable
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily
by converted into a cash value, describe the consideration:
$2,999,998.80
Number of financial products to which the transaction related: 1,666,666
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed
period) include the following details—
Whether relevant interests were acquired or disposed of during a closed period:Not applicable
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Not applicable
Date of the prior written clearance (if any):
Not applicable
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Not applicable
Nature of relevant interest:
Not applicable
For that relevant interest,-
Number held in class:
Not applicable
Current registered holder(s):
Not applicable
For a derivative relevant interest,-
Type of derivative:
Not applicable
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative (if any):
Not applicable
The price's specified terms (if any):
Not applicable
Any other details needed to understand how the amount of the consideration
payable under the derivative or the value of the derivative is affected by the value of
the underlying financial products:
Not applicable
For that derivative relevant interest,-
Not applicable
Parties to the derivative: Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Certification
I, certify that, to the best of my knowledge and belief, the information contained in
this disclosure is correct and that I am duly authorised to make this disclosure by
all persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
5 September 2022
Name and title of authorised person:
Phoebe Gibbons, General Counsel

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Heartland Group Holdings Limited
Date this disclosure made:
5 September 2022
Date of last disclosure:
31 March 2022
Director or senior manager giving disclosure
Full name(s):
Bruce Robertson Irvine
Name of listed issuer:
Heartland Group Holdings Limited
Name of related body corporate (if applicable):
Heartland Bank Limited
Position held in listed issuer:
Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary Shares in Heartland
Group Holdings Limited (NZX/ASX:
HGH)
Nature of the affected relevant interest(s):
Beneficial Owner
For that relevant interest-
Number held in class before acquisition or disposal:
479,539
Number held in class after acquisition or disposal:
504,539
Current registered holder(s):
Mary Therese Irvine
Registered holder(s) once transfers are registered:
Not applicable
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Not applicable
Class of underlying financial products:
Not applicable
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative(if any):
Not applicable
The price specified in the terms of the derivative (if any):
Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative,-
Parties to the derivative:
Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1

Details of transactions requiring disclosure-
Date of transaction:29 August 2022
Nature of transaction:
Acqusition of shares under
Heartland's fully underwritten
NZ$130 million placement
announced on 23 August 2022.
Name of any other party or parties to the transaction (if known):Not applicable
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
$45,000.00
Number of financial products to which the transaction related: 25,000
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:Not applicable
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Not applicable
Date of the prior written clearance (if any):
Not applicable
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Ordinary Shares in Heartland
Group Holdings Limited (NZX/ASX:
HGH)
Nature of relevant interest:
Registered Holder and Beneficial
Owner
For that relevant interest,-
Number held in class:
138,283
Current registered holder(s):
Bruce Robertson Irvine
For a derivative relevant interest,-
Type of derivative:
Not applicable
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative (if any):
Not applicable
The price's specified terms (if any):
Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative relevant interest,-
Not applicable
Parties to the derivative: Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
5 September 2022
Name and title of authorised person:
Phoebe Gibbons, General Counsel

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Heartland Group Holdings Limited
Date this disclosure made:
5 September 2022
Date of last disclosure:
16 April 2021
Director or senior manager giving disclosure
Full name(s):
Kathryn Mitchell (Morrison)
Name of listed issuer:
Heartland Group Holdings Limited
Name of related body corporate (if applicable):
Not applicable
Position held in listed issuer:
Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary Shares in Heartland Group
Holdings Limited (NZX/ASX: HGH)
Nature of the affected relevant interest(s):
Registered Holder and Beneficial Owner
For that relevant interest-
Number held in class before acquisition or disposal:
0
Number held in class after acquisition or disposal:
55,000
Current registered holder(s):
Kathryn Mitchell (Morrison)
Registered holder(s) once transfers are registered:
Not applicable
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Not applicable
Class of underlying financial products:
Not applicable
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative(if any):
Not applicable
The price specified in the terms of the derivative (if any):
Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative,-
Parties to the derivative:
Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1

Details of transactions requiring disclosure-
Date of transaction:29 August 2022
Nature of transaction:
Acquisition of shares under Heartland's
fully underwritten NZ$130 million
placement announced on 23 August
2022.
Name of any other party or parties to the transaction (if known):Not applicable
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
$99,000.00
Number of financial products to which the transaction related: 55,000
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:Not applicable
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Not applicable
Date of the prior written clearance (if any):
Not applicable
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Ordinary Shares in Heartland Group
Holdings Limited (NZX/ASX: HGH)
Nature of relevant interest:
Beneficial Owner
For that relevant interest,-
Number held in class:53,088
Current registered holder(s):Kathryn Mitchell (Morrison)
For a derivative relevant interest,-
Type of derivative:
Not applicable
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative (if any):
Not applicable
The price's specified terms (if any):
Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative relevant interest,-
Not applicable
Parties to the derivative: Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
5 September 2022
Name and title of authorised person:
Phoebe Gibbons, General Counsel

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Heartland Group Holdings Limited
Date this disclosure made:
5 September 2022
Date of last disclosure:
11 December 2020
Director or senior manager giving disclosure
Full name(s):
Jeffrey Kenneth Greenslade
Name of listed issuer:
Heartland Group Holdings Limited
Name of related body corporate (if applicable):
Not applicable
Position held in listed issuer:
Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary Shares in Heartland Group
Holdings Limited (NZX/ASX: HGH)
Nature of the affected relevant interest(s):
Registered Holder and Beneficial
Owner
For that relevant interest-
Number held in class before acquisition or disposal:
1,993,078
Number held in class after acquisition or disposal:
2,020,855
Current registered holder(s):
Jeffrey Kenneth Greenslade
Registered holder(s) once transfers are registered:
Not applicable
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Not applicable
Class of underlying financial products:
Not applicable
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative(if any):
Not applicable
The price specified in the terms of the derivative (if any):
Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative,-
Parties to the derivative:
Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1

Details of transactions requiring disclosure-
Date of transaction:29 August 2022
Nature of transaction:
Acquisition of shares under
Heartland's fully underwritten
NZ$130 million placement
announced on 23 August 2022.
Name of any other party or parties to the transaction (if known):Not applicable
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
$49,998.60
Number of financial products to which the transaction related: 27,777
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:Not applicable
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Not applicable
Date of the prior written clearance (if any):
Not applicable
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Not applicable
Nature of relevant interest:
Not applicable
For that relevant interest,-
Number held in class:
Not applicable
Current registered holder(s):
Not applicable
For a derivative relevant interest,-
Type of derivative:
Not applicable
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative (if any):
Not applicable
The price's specified terms (if any):
Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative relevant interest,-
Not applicable
Parties to the derivative: Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
5 September 2022
Name and title of authorised person:
Phoebe Gibbons, General Counsel

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Heartland Group Holdings Limited
Date this disclosure made:
5 September 2022
Date of last disclosure:
24 September 2019
Director or senior manager giving disclosure
Full name(s):
Gregory Raymond Tomlinson
Name of listed issuer:
Heartland Group Holdings Limited
Name of related body corporate (if applicable):
Not applicable
Position held in listed issuer:
Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary Shares in Heartland Group
Holdings Limited (NZX/ASX: HGH)
Nature of the affected relevant interest(s):
Harrogate Trustee Limited or its directors
are accustomed to act in accordance with
Gregory Raymond Tomlinson's wishes in
relation to a relevant interest held by
Harrogate Trustee Limited.
For that relevant interest-
Number held in class before acquisition or disposal:
58,392,997
Number held in class after acquisition or disposal:
69,335,936
Current registered holder(s):
Harrogate Trustee Limited
Registered holder(s) once transfers are registered:
Not applicable
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Not applicable
Class of underlying financial products:
Not applicable
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative(if any):
Not applicable
The price specified in the terms of the derivative (if any):
Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative,-
Parties to the derivative:
Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1

Details of transactions requiring disclosure-
Date of transaction:29 August 2022
Nature of transaction:
Acquisition of shares under Heartland's fully
underwritten NZ$130 million placement
announced on 23 August 2022.
Name of any other party or parties to the transaction (if known):Not applicable
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
$19,697,290.20
Number of financial products to which the transaction related: 10,942,939
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:Not applicable
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Not applicable
Date of the prior written clearance (if any):
Not applicable
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Not applicable
Nature of relevant interest:
Not applicable
For that relevant interest,-
Number held in class:
Not applicable
Current registered holder(s):
Not applicable
For a derivative relevant interest,-
Type of derivative:
Not applicable
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative (if any):
Not applicable
The price's specified terms (if any):
Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative relevant interest,-
Not applicable
Parties to the derivative: Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
5 September 2022
Name and title of authorised person:
Phoebe Gibbons, General Counsel